Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) EPS (Basic): 2009-2024

Historic EPS (Basic) for Iovance Biotherapeutics (IOVA) over the last 13 years, with Dec 2024 value amounting to -$1.28.

  • Iovance Biotherapeutics' EPS (Basic) rose 10.71% to -$0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.19, marking a year-over-year increase of 20.13%. This contributed to the annual value of -$1.28 for FY2024, which is 32.28% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported EPS (Basic) of -$1.28 as of FY2024, which was up 32.28% from -$1.89 recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' EPS (Basic) ranged from a high of -$1.28 in FY2024 and a low of -$2.49 during FY2022.
  • Moreover, its 3-year median value for EPS (Basic) was -$1.89 (2023), whereas its average is -$1.89.
  • Per our database at Business Quant, Iovance Biotherapeutics' EPS (Basic) decreased by 11.66% in 2022 and then skyrocketed by 32.28% in 2024.
  • Yearly analysis of 4 years shows Iovance Biotherapeutics' EPS (Basic) stood at -$2.23 in 2021, then declined by 11.66% to -$2.49 in 2022, then increased by 24.10% to -$1.89 in 2023, then skyrocketed by 32.28% to -$1.28 in 2024.